Z-1132-2021 Class II Terminated
FDA device recall Z-1132-2021 was initiated by LumiraDx on Jan 11, 2021 and is designated Class II. Reason for recall: Observations of potential false positive results in the specified lots. Use of these test strips may result in false positive patient test results and potential exposure to unnecessary treatment or… The recall status is terminated (terminated Dec 3, 2021). Affected quantity: 3,274,272 strips (Updated 3/15/2021 added 69,168 strips).
Recall details
- Product Type
- Devices
- Report Date
- Feb 24, 2021
- Initiation Date
- Jan 11, 2021
- Termination Date
- Dec 3, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,274,272 strips (Updated 3/15/2021 added 69,168 strips)
Product description
LumiraDx SARS-CoV-2 Ag Test Strip Kit US EUA (48 Tests / EN). LumiraDx Severe Acute Respiratory Syndrome (SARS) CoV-2 Antigen (Ag) Test Strips, Catalog #:L016000109048. Part of the LumiraDx Platform, a point of care system for professional use for in vitro diagnostic tests. It comprises a portable LumiraDx Instrument and a LumiraDx Test Strip for the required test.
Reason for recall
Observations of potential false positive results in the specified lots. Use of these test strips may result in false positive patient test results and potential exposure to unnecessary treatment or quarantine.
Distribution pattern
Worldwide distribution. US states of CA, GA, PA, SD. (Updated 3/15/2021) Austria, Germany, Ireland, Italy, Lebanon, Netherlands, Slovenia, Spain, United Kingdom.
Code information
Catalog #:L016000109048 Lot #: 5000269 (GM2000238), 5000280 (GM2000232), 5000306 (GM2000261) (Updated 3/15/2021) 5000323 (GM2000354), 6000142 (GM2000296), 6000100 (GM2000322)
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1132-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026